Quality of life assessment instruments for radiodermatitis in cancer patients: scoping review.
Letícia Moraes Lopes, Beatriz Nappo Neiva, Beatriz Regina Lima de Aguiar and 3 others
PMID 41191697WHAT IT FOUND
Skin-related quality-of-life tools were used across 32 studies in cancer patients with radiodermatitis, mainly Skindex-16 and DLQI.
Both have Portuguese validation, but there is no consensus on the best instrument for assessing radiodermatitis impact.
Key findings
01The review included 32 studies and identified DLQI, Skindex-16, Skindex-29, and PSRQ as skin-related quality-of-life instruments.
02Skindex-16 and DLQI were the most used instruments and have Portuguese-language validation.
03The review found no consolidated guideline on the choice of the best instrument for this clinical context.
STILL TO COME
How it was doneWhat they foundWhat it means for RNs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
Only 32 studies were included, so the map is narrow. Many studies measured QoL as a secondary outcome, so the evidence is not strong enough to choose a best instrument. 23 studies could not be retrieved because of access restrictions, and 13 grey-literature studies were not retrieved.
The easy way to misread this
Do not read this as evidence that any instrument improves radiodermatitis care or patient outcomes. The review only mapped which QoL tools were used in included studies; it did not test effectiveness.